Detail of the clinical trial
| Title of the trial | A phase II, multi-centre study investiaging the safety and efficacy of ofatumumab and bendamustine combination in patients with untreated or relapsed chronic lymphocytic leukaemia (CLL) |
|---|---|
| EudraCT number | 2011-005178-43 |
| Protocol number | OMB115991 |
| Sponsor | GlaxoSmithKline Research & Development Limited, UK |
| Indications | Hemato-oncology |
| Diagnosis | relapsed chronic lymphocytic leukemia |
| Population in clinical trial |
Adults (18-65 years) Elderly ( > 65 years) Male Female Patients |
| Year of receiving the request to Institute (SÚKL) | 2011 |
| Date of approval by Institute (SÚKL) | 18.1.2012 |
| Date of approval by EC | 8.2.2012 |
| Date of initiation CT in ČR | 28.3.2012 |
| Date of ending CT in ČR | 11.2.2016 |
| Notice | |
| Sites |
VFN, I. interní klinika, Praha FN Olomouc, Hematoonkologická klinika FN Hradec Králové, 2. interní klinika odd. klinické hematologie FN Brno, IHOK |
cz